Fig. 5

Recurrence-free survival (RFS), 1p deletion and distribution across molecular groups (MGs) of atypical meningioma according to histopathological features. BIOB meningiomas had significantly lower frequency of 1p deletion and MCM2 immunostaining (used as a surrogate for MG4). Patients with these tumors had significantly longer RFS